Browsing Tag
neuroendocrine tumors
3 posts
Whitehawk Therapeutics (Nasdaq: WHWK) stock focus sharpens as ASCO 2026 data support SEZ6 ADC strategy in small cell lung cancer
Find out how Whitehawk Therapeutics’ SEZ6 data at ASCO 2026 could shape its HWK-206 ADC strategy in small cell lung cancer.
Will CABOMETYX secure EU approval for advanced neuroendocrine tumors after CHMP’s positive opinion?
Ipsen’s CABOMETYX receives EMA's CHMP backing for advanced neuroendocrine tumors; EU approval expected in 2025 following FDA nod.
Amryt gets FDA orphan drug designation for Mycapssa for carcinoid syndrome
Amryt, a commercial-stage biopharma company, has secured orphan drug designation for Mycapssa (octreotide capsules) from the US Food…